Literature DB >> 27756846

SYVN1, NEDD8, and FBXO2 Proteins Regulate ΔF508 Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Ubiquitin-mediated Proteasomal Degradation.

Shyam Ramachandran1, Samantha R Osterhaus1, Kalpaj R Parekh1, Ashley M Jacobi2, Mark A Behlke2, Paul B McCray3.   

Abstract

We previously reported that delivery of a microRNA-138 mimic or siRNA against SIN3A to cultured cystic fibrosis (ΔF508/ΔF508) airway epithelia partially restored ΔF508-cystic fibrosis transmembrane conductance regulator (CFTR)-mediated cAMP-stimulated Cl- conductance. We hypothesized that dissecting this microRNA-138/SIN3A-regulated gene network would identify individual proteins contributing to the rescue of ΔF508-CFTR function. Among the genes in the network, we rigorously validated candidates using functional CFTR maturation and electrolyte transport assays in polarized airway epithelia. We found that depletion of the ubiquitin ligase SYVN1, the ubiquitin/proteasome system regulator NEDD8, or the F-box protein FBXO2 partially restored ΔF508-CFTR-mediated Cl- transport in primary cultures of human cystic fibrosis airway epithelia. Moreover, knockdown of SYVN1, NEDD8, or FBXO2 in combination with corrector compound 18 further potentiated rescue of ΔF508-CFTR-mediated Cl- conductance. This study provides new knowledge of the CFTR biosynthetic pathway. It suggests that SYVN1 and FBXO2 represent two distinct multiprotein complexes that may degrade ΔF508-CFTR in airway epithelia and identifies a new role for NEDD8 in regulating ΔF508-CFTR ubiquitination.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  E3 ubiquitin ligase; airway epithelia; cystic fibrosis; endoplasmic-reticulum-associated protein degradation (ERAD); neddylation; proteostasis; ubiquitylation (ubiquitination)

Mesh:

Substances:

Year:  2016        PMID: 27756846      PMCID: PMC5207249          DOI: 10.1074/jbc.M116.754283

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  66 in total

1.  The tumor autocrine motility factor receptor, gp78, is a ubiquitin protein ligase implicated in degradation from the endoplasmic reticulum.

Authors:  S Fang; M Ferrone; C Yang; J P Jensen; S Tiwari; A M Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-27       Impact factor: 11.205

2.  The Hsc70 co-chaperone CHIP targets immature CFTR for proteasomal degradation.

Authors:  G C Meacham; C Patterson; W Zhang; J M Younger; D M Cyr
Journal:  Nat Cell Biol       Date:  2001-01       Impact factor: 28.824

3.  Derlin-1 promotes the efficient degradation of the cystic fibrosis transmembrane conductance regulator (CFTR) and CFTR folding mutants.

Authors:  Fei Sun; Ruilin Zhang; Xiaoyan Gong; Xuehui Geng; Peter F Drain; Raymond A Frizzell
Journal:  J Biol Chem       Date:  2006-09-05       Impact factor: 5.157

4.  Human HRD1 is an E3 ubiquitin ligase involved in degradation of proteins from the endoplasmic reticulum.

Authors:  Marjolein Kikkert; Ram Doolman; Min Dai; Rachel Avner; Gerco Hassink; Sjaak van Voorden; Swapna Thanedar; Joseph Roitelman; Vincent Chau; Emmanuel Wiertz
Journal:  J Biol Chem       Date:  2003-10-30       Impact factor: 5.157

5.  An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer.

Authors:  Teresa A Soucy; Peter G Smith; Michael A Milhollen; Allison J Berger; James M Gavin; Sharmila Adhikari; James E Brownell; Kristine E Burke; David P Cardin; Stephen Critchley; Courtney A Cullis; Amanda Doucette; James J Garnsey; Jeffrey L Gaulin; Rachel E Gershman; Anna R Lublinsky; Alice McDonald; Hirotake Mizutani; Usha Narayanan; Edward J Olhava; Stephane Peluso; Mansoureh Rezaei; Michael D Sintchak; Tina Talreja; Michael P Thomas; Tary Traore; Stepan Vyskocil; Gabriel S Weatherhead; Jie Yu; Julie Zhang; Lawrence R Dick; Christopher F Claiborne; Mark Rolfe; Joseph B Bolen; Steven P Langston
Journal:  Nature       Date:  2009-04-09       Impact factor: 49.962

6.  CFTR in Calu-3 human airway cells: channel properties and role in cAMP-activated Cl- conductance.

Authors:  C Haws; W E Finkbeiner; J H Widdicombe; J J Wine
Journal:  Am J Physiol       Date:  1994-05

7.  Mechanism-based corrector combination restores ΔF508-CFTR folding and function.

Authors:  Tsukasa Okiyoneda; Guido Veit; Johanna F Dekkers; Miklos Bagdany; Naoto Soya; Haijin Xu; Ariel Roldan; Alan S Verkman; Mark Kurth; Agnes Simon; Tamas Hegedus; Jeffrey M Beekman; Gergely L Lukacs
Journal:  Nat Chem Biol       Date:  2013-05-12       Impact factor: 15.040

8.  A microRNA network regulates expression and biosynthesis of wild-type and DeltaF508 mutant cystic fibrosis transmembrane conductance regulator.

Authors:  Shyam Ramachandran; Philip H Karp; Peng Jiang; Lynda S Ostedgaard; Amy E Walz; John T Fisher; Shaf Keshavjee; Kim A Lennox; Ashley M Jacobi; Scott D Rose; Mark A Behlke; Michael J Welsh; Yi Xing; Paul B McCray
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-01       Impact factor: 11.205

Review 9.  MLN4924: a novel first-in-class inhibitor of NEDD8-activating enzyme for cancer therapy.

Authors:  Steffan T Nawrocki; Patrick Griffin; Kevin R Kelly; Jennifer S Carew
Journal:  Expert Opin Investig Drugs       Date:  2012-07-16       Impact factor: 6.206

Review 10.  Drugging the undruggables: exploring the ubiquitin system for drug development.

Authors:  Xiaodong Huang; Vishva M Dixit
Journal:  Cell Res       Date:  2016-03-22       Impact factor: 25.617

View more
  17 in total

Review 1.  The evolving role of ubiquitin modification in endoplasmic reticulum-associated degradation.

Authors:  G Michael Preston; Jeffrey L Brodsky
Journal:  Biochem J       Date:  2017-02-15       Impact factor: 3.857

2.  Urinary metabolomics reveals unique metabolic signatures in infants with cystic fibrosis.

Authors:  B T Kopp; E Joseloff; D Goetz; B Ingram; S L Heltshe; D H Leung; B W Ramsey; K McCoy; D Borowitz
Journal:  J Cyst Fibros       Date:  2018-11-23       Impact factor: 5.482

Review 3.  Innovative Therapies for Cystic Fibrosis: The Road from Treatment to Cure.

Authors:  Giulio Cabrini
Journal:  Mol Diagn Ther       Date:  2019-04       Impact factor: 4.074

4.  SUMOylation represses the transcriptional activity of the Unfolded Protein Response transducer ATF6.

Authors:  Xia Hou; Zhao Yang; Kezhong Zhang; Deyu Fang; Fei Sun
Journal:  Biochem Biophys Res Commun       Date:  2017-10-20       Impact factor: 3.575

5.  Destruction or Reconstruction: A Subtle Liaison between the Proteolytic and Signaling Role of Protein Ubiquitination in Spermatogenesis.

Authors:  Giovanna Berruti
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

6.  CK19 stabilizes CFTR at the cell surface by limiting its endocytic pathway degradation.

Authors:  Xia Hou; Qingtian Wu; Carthic Rajagopalan; Chunbing Zhang; Mohamad Bouhamdan; Hongguang Wei; Xuequn Chen; Khalequz Zaman; Chunying Li; Xiaonan Sun; Song Chen; Raymond A Frizzell; Fei Sun
Journal:  FASEB J       Date:  2019-08-26       Impact factor: 5.834

7.  Assessment of p.Phe508del-CFTR functional restoration in pediatric primary cystic fibrosis airway epithelial cells.

Authors:  Erika N Sutanto; Amelia Scaffidi; Luke W Garratt; Kevin Looi; Clara J Foo; Michela A Tessari; Richard A Janssen; David F Fischer; Stephen M Stick; Anthony Kicic
Journal:  PLoS One       Date:  2018-01-23       Impact factor: 3.240

Review 8.  Peripheral Protein Quality Control as a Novel Drug Target for CFTR Stabilizer.

Authors:  Ryosuke Fukuda; Tsukasa Okiyoneda
Journal:  Front Pharmacol       Date:  2018-09-27       Impact factor: 5.810

9.  Trafficking, localization and degradation of the Na+,HCO3- co-transporter NBCn1 in kidney and breast epithelial cells.

Authors:  Christina Wilkens Olesen; Jens Vogensen; Ida Axholm; Marc Severin; Julie Schnipper; Isabella Skandorff Pedersen; Jakob Hjorth von Stemann; Jacob Morville Schrøder; Dan Ploug Christensen; Stine Falsig Pedersen
Journal:  Sci Rep       Date:  2018-05-09       Impact factor: 4.379

Review 10.  Transcriptomic and Proteostasis Networks of CFTR and the Development of Small Molecule Modulators for the Treatment of Cystic Fibrosis Lung Disease.

Authors:  Matthew D Strub; Paul B McCray
Journal:  Genes (Basel)       Date:  2020-05-13       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.